Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,257 | 178,872 | 176,954 | 169,878 | 122,975 |
| Marketable Securities | 197,539 | 197,676 | 246,459 | 359,775 | 464,109 |
| Receivables | 7,294 | 6,362 | 8,587 | 7,689 | 7,720 |
| TOTAL | $340,065 | $398,769 | $447,396 | $554,064 | $606,944 |
| Non-Current Assets | |||||
| PPE Net | 51,600 | 51,523 | 50,816 | 49,588 | 45,222 |
| Investments And Advances | 82,515 | 88,169 | 95,631 | 49,205 | 42,431 |
| Intangibles | 91,614 | 93,462 | 95,458 | 97,799 | 96,577 |
| Other Non-Current Assets | 88,516 | 90,000 | 83,097 | 84,707 | 85,921 |
| TOTAL | $314,245 | $323,154 | $325,002 | $281,299 | $270,151 |
| Total Assets | $654,310 | $721,923 | $772,398 | $835,363 | $877,095 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,147 | 9,759 | 7,982 | 10,132 | 11,638 |
| Accrued Expenses | 12,493 | 20,840 | 18,646 | 17,406 | 13,077 |
| TOTAL | $118,526 | $127,887 | $131,898 | $136,943 | $132,839 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 80,783 | 85,711 | 90,454 | 93,957 | 94,364 |
| Other Non-Current Liabilities | 44,051 | 45,272 | 43,752 | 44,758 | 45,697 |
| TOTAL | $201,262 | $218,693 | $234,484 | $252,963 | $274,839 |
| Total Liabilities | $319,788 | $346,580 | $366,382 | $389,906 | $407,678 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,687 | 145,968 | 145,675 | 145,337 | 143,882 |
| Common Shares | 1,467 | 1,459 | 1,455 | 1,451 | 1,437 |
| Retained earnings | -1,000,244 | -956,267 | -918,771 | -871,083 | -823,914 |
| Other shareholders' equity | -6,955 | -3,987 | -623 | 1,987 | -224 |
| TOTAL | $334,522 | $375,343 | $406,016 | $445,457 | $469,417 |
| Total Liabilities And Equity | $654,310 | $721,923 | $772,398 | $835,363 | $877,095 |